High Growth Tech Stocks In Sweden You Should Know
As global markets show signs of recovery, with technology stocks leading the charge, Sweden's tech sector is also experiencing significant momentum. In this article, we will explore three high-growth tech stocks in Sweden that have been making waves in the market. A good stock in this environment typically demonstrates strong innovation potential and resilience amidst economic shifts.
Top 10 High Growth Tech Companies In Sweden
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Truecaller | 20.32% | 21.61% | ★★★★★★ |
Fortnox | 20.18% | 22.60% | ★★★★★★ |
Bonesupport Holding | 33.76% | 31.20% | ★★★★★★ |
Xbrane Biopharma | 58.38% | 105.19% | ★★★★★★ |
Skolon | 31.76% | 121.72% | ★★★★★★ |
Yubico | 22.52% | 43.69% | ★★★★★★ |
Hemnet Group | 20.13% | 25.41% | ★★★★★★ |
Sileon | 40.13% | 109.34% | ★★★★★★ |
BioArctic | 39.57% | 102.80% | ★★★★★★ |
KebNi | 34.75% | 86.11% | ★★★★★★ |
We'll examine a selection from our screener results.
BioArctic
Simply Wall St Growth Rating: ★★★★★★
Overview: BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden and has a market cap of SEK14.05 billion.
Operations: BioArctic AB focuses on developing biological drugs for central nervous system disorders, generating revenue primarily from its biotechnology segment, which amounted to SEK252.21 million. The company operates within the Swedish market and has a market cap of SEK14.05 billion.
BioArctic's significant strides in Alzheimer's treatment, particularly with Leqembi?, highlight its innovative edge. The recent UAE approval for Leqembi? underscores the drug’s potential impact on early-stage Alzheimer’s patients. With a forecasted annual revenue growth of 39.6% and earnings expected to surge by 102.8% per year, the company shows robust growth prospects despite current unprofitability. Notably, BioArctic's collaborative model with Eisai minimizes development costs while securing a 9% royalty on global sales, positioning it favorably in the biotech sector.
Dive into the specifics of BioArctic here with our thorough health report.
Evaluate BioArctic's historical performance by accessing our past performance report.
Hemnet Group
Simply Wall St Growth Rating: ★★★★★★
Overview: Hemnet Group AB (publ) operates a residential property platform in Sweden and has a market cap of SEK37.29 billion.
Operations: Hemnet Group AB (publ) generates revenue primarily through its residential property platform in Sweden, with SEK1.21 billion coming from internet information providers. The company focuses on providing digital advertising and subscription services to real estate agents and private sellers.
Hemnet Group’s forecasted earnings growth of 25.4% per year significantly outpaces the Swedish market's 16%. Revenue is expected to grow at 20.1% annually, indicating robust performance compared to the market's modest 1.1%. In Q2 2024, Hemnet reported sales of SEK 405 million, up from SEK 267.6 million a year ago, with net income rising to SEK 148.7 million from SEK 91.9 million last year. The company repurchased approximately SEK 56.1 million worth of shares between May and June this year, reflecting confidence in its future prospects.
Get an in-depth perspective on Hemnet Group's performance by reading our health report here.
Assess Hemnet Group's past performance with our detailed historical performance reports.
Sectra
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Sectra AB (publ) specializes in medical IT and cybersecurity solutions across Sweden, the United Kingdom, the Netherlands, and other parts of Europe, with a market cap of SEK46.90 billion.
Operations: With a market cap of SEK46.90 billion, Sectra AB (publ) generates revenue primarily from its Imaging IT Solutions (SEK2.55 billion) and Secure Communications (SEK367.35 million) segments. The company focuses on delivering specialized medical IT and cybersecurity solutions across various European regions, including Sweden, the United Kingdom, and the Netherlands.
Sectra's revenue surged to SEK 3.04 billion in the latest fiscal year, up from SEK 2.41 billion, reflecting a robust growth trajectory of 14.7% annually, outpacing the Swedish market's modest 1.1%. The company's strategic focus on R&D is evident with significant investments enhancing its enterprise imaging solutions and cybersecurity offerings like Sectra Tiger, which recently secured a renewed contract with NATO's NCI Agency. Moreover, the successful deployment of Sectra One Cloud in Belgian hospitals underscores its innovative edge in managed cloud services for healthcare.
Click here and access our complete health analysis report to understand the dynamics of Sectra.
Review our historical performance report to gain insights into Sectra's's past performance.
Summing It All Up
Reveal the 80 hidden gems among our Swedish High Growth Tech and AI Stocks screener with a single click here.
Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Ready For A Different Approach?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OM:BIOA B OM:HEM and OM:SECT B.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]